Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of epidermal cell differentiation. [GOC:go_curators]
Epidermal cell differentiation is a tightly regulated process that involves a complex interplay of signaling pathways, transcription factors, and epigenetic modifications. The process begins with the activation of epidermal stem cells located in the basal layer of the epidermis. These stem cells undergo asymmetric division, giving rise to one daughter cell that remains a stem cell and another that commits to differentiation. The differentiating cell will move upwards through the epidermal layers, undergoing a series of changes that ultimately lead to the formation of a terminally differentiated keratinocyte. These cells are highly specialized, producing keratin, a fibrous protein that provides structural support and protection to the skin.
The process of epidermal cell differentiation is regulated by a variety of signaling pathways, including the Wnt, Notch, and TGF-β pathways. These pathways influence the expression of a range of transcription factors, which in turn control the expression of genes involved in keratinocyte differentiation.
The Wnt signaling pathway plays a crucial role in maintaining the pool of epidermal stem cells. Activation of this pathway promotes the proliferation and self-renewal of stem cells, while inhibition of Wnt signaling promotes differentiation.
The Notch signaling pathway plays a role in the commitment of epidermal stem cells to differentiate. This pathway can activate transcription factors that promote keratinocyte differentiation, such as the bHLH protein family members, which regulate the expression of genes involved in keratinization.
The TGF-β signaling pathway also plays a role in epidermal cell differentiation. This pathway can activate transcription factors that promote differentiation, such as the SMAD family of proteins.
Epigenetic modifications, such as histone acetylation and DNA methylation, also play a role in regulating epidermal cell differentiation. These modifications can alter the accessibility of DNA to transcription factors, thereby regulating gene expression.
The regulation of epidermal cell differentiation is a complex process that is tightly controlled by a variety of signaling pathways, transcription factors, and epigenetic modifications. This precise regulation ensures that the epidermis is properly formed and maintained, providing a protective barrier against the environment.
'"
Protein | Definition | Taxonomy |
---|---|---|
Kelch-like ECH-associated protein 1 | A kelch-like ECH-associated protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14145] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
3-phenylpropionic acid | 3-phenylpropionic acid : A monocarboxylic acid that is propionic acid substituted at position 3 by a phenyl group. 3-phenylpropionic acid: RN given refers to parent cpd | benzenes; monocarboxylic acid | antifungal agent; human metabolite; plant metabolite |
sulforaphane | sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen. sulforaphane: from Cardaria draba L. | isothiocyanate; sulfoxide | antineoplastic agent; antioxidant; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite |
1-naphthylamine | 1-naphthylamine : A naphthylamine that is naphthalene substituted by an amino group at position 1. 1-Naphthylamine: A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic. naphthylamine : A primary arylamine that is naphthalene substituted by an amino group at unspecified position. | naphthylamine | human xenobiotic metabolite |
iberin | isothiocyanate; sulfoxide | apoptosis inducer; plant metabolite; quorum sensing inhibitor | |
3-morpholinopropylamine | 3-morpholinopropylamine : A member of the class of morpholines that is morpholine substituted by a 3-aminopropyl group a the N atom. | morpholines; primary amino compound | |
2,4'-bisphenol f | 2,4'-bisphenol F: contact allergen; structure given in first source | ||
hei 712 | organofluorine compound; quinolone | ||
2-(5-Chlorobenzo[b]thiophen-3-yl)acetic acid | 1-benzothiophenes | ||
alyssin | sulfoxide | ||
dimethyl fumarate | diester; enoate ester; methyl ester | antipsoriatic; immunomodulator | |
umi-77 | UMI-77: an Mcl-1 inhibitor; structure in first source | ||
6-methylsulfinylhexyl isothiocyanate | 6-(Methylsulfinyl)hexyl isothiocyanate: showed a dose-dependent inhibition of LPS-induced nitric oxide (NO), iNOS mRNA and protein. | sulfoxide | |
(1S,2R)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid | LH601A: inhibits the interaction between KEAP1 and NRF2; structure in first source | phthalimides | |
nk 252 | NK 252: potentiates the action of antitumor drugs against drug-sensitive tumors; structure given in first source |